Large-scale expansion of rat CD4+ CD25+ T reg cells in the absence of T-cell receptor stimulation

Immunology

Volumn 119, Issue 4, 2006, Pages 441-450

  Beyersdorf, Niklas ^a   Balbach, Karen ^a   Hünig, Thomas ^a   Kerkau, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anergy suppression tolerance; Co stimulation costimulatory molecules; Proliferation; Regulatory T cells (Treg)

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY CD28; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; OBSERVATION; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; IMMUNE TOLERANCE; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 33750846654     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02455.x     Document Type: Article

References (42)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
2. + T cell receptors. Immunity 2004; 21:267-77.
3. + regulatory T cells. Nat Immunol 2003; 4:330-6.
4. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-41.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
6. + T regulatory cells. Nat Immunol 2003; 4:337-42.
7. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr Opin Immunol 2000; 12:684-90.
8. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199:971-9.
9. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200:277-85.
10. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4 (+) CD25 (+) T-cells from patients with type 1 diabetes. Diabetes 2005; 54:92-9.
11. Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999; 189:877-82.
12. Garza KM, Agersborg SS, Baker E, Tung KS. Persistence of physiological self antigen is required for the regulation of self tolerance. J Immunol 2000; 164:3982-9.
13. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12:431-40.
14. + regulatory T cells. J Immunol 2003; 171:3348-52.
15. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3 (+) CD25 (+) CD4 (+) regulatory T cells by interleukin (IL) -2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201:723-35.
16. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4:665-74.
17. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6:152-62.
18. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199:1467-77.
19. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4 (+) CD25 (+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99:3493-9.
20. Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199:1455-65.
21. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale in vitro expansion of polyclonal human CD4 (+) CD25high regulatory T cells. Blood 2004; 104:895-903.
22. Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 2003; 33:626-38.
23. Beyersdorf N, Gaupp S, Balbach K et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 2005; 202:445-55.
24. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25 (+) regulatory T cells convey suppressor activity to conventional CD4 (+) T helper cells. J Exp Med 2002; 196:255-60.
25. + Tregs. J Clin Invest 2005; 115:3276-84.
26. + Tregs: limiting collateral damage. J Clin Invest 2004; 114:1372-8.
27. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182:207-14.
28. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:1969-80.
29. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164:183-90.
30. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
31. + T cell suppressor function. J Immunol 2004; 172:6519-23.
32. + regulatory T cell function. Eur J Immunol 2004; 34:2480-8.
33. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ. Interleukin 2 signaling is required for CD4 (+) regulatory T cell function. J Exp Med 2002; 196:851-7.
34. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 2005; 17:279-88.
35. Waldmann H, Cobbold S. Exploiting tolerance processes in transplantation. Science 2004; 305:209-12.
36. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4 (+) CD25 (+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 2002; 196:247-53.
37. + T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004; 173:267-74.
38. Kerstan A, Hunig T. Cutting edge. distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells. J Immunol 2004; 172:1341-5.
39. + regulatory T cell activity: it takes (IL-)two to tango. Eur J Immunol 2005; 35:1336-41.
40. + T cells. J Immunol 2004; 173:5008-20.
41. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of OX40 (CD134) on CD4 (+) CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 2005; 105:2845-51.
42. Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003; 3:939-51.